Enhabit, Inc. operates as a provider of home health and hospice services across the United States. The company delivers home health services including wound care, infusion therapy, pain management, cardiac rehabilitation, and skilled nursing assessment. It also provides disease management programs for chronic conditions such as diabetes, congestive heart failure, Parkinson's disease, and respiratory diseases, supported by physical, occupational, and speech therapy services. The hospice segment offers palliative care, symptom management, spiritual and bereavement counseling, and psychosocial support for terminally ill patients and their families.
The company operates primarily through two service lines: home health and hospice care. Home health represents the larger revenue segment, encompassing skilled nursing visits, therapy services, and patient education delivered in patient homes. Hospice services focus on end-of-life care and family support.
Based in Dallas, Texas, Enhabit operates with approximately 10,700 full-time employees and maintains a presence across multiple U.S. markets. The company was incorporated in Delaware and trades on the NYSE. It was formerly known as Encompass Health Home Health Holdings, Inc. prior to its name change in March 2022 and traces its origins to 1998.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-3.11 | $-3.11 | -93.2% | |
| 2023 | $-1.61 | $-1.61 | -98.8% | |
| 2022 | $-0.81 | $-0.81 | — |